← Leaderboards
Mark W Geraci
University Of Colorado Denver
$20,364,365
Attributed
$46,186,747
Total exposure
19
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.4M · FY2005–19$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$46,672,692 · 21
By mechanism
RC2$11,401,676 · 1
UL1$10,572,559 · 1
R24$7,611,666 · 1
R01$5,484,434 · 3
P30$3,085,401 · 3
T32$2,836,187 · 2
Top collaborators
- Stephanie Duggins Davis4 shared
- Serpil C. Erzurum4 shared
- William E. Grizzle4 shared
- Vallerie Mclaughlin4 shared
- Marlene Rabinovitch4 shared
- Naftali Kaminski3 shared
- John Quackenbush3 shared
- David Albert Schwartz3 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Raphael A. Nemenoff$15,000,654
- John K Hewitt$34,018,905
- York E Miller$6,348,289
- Paul A Bunn$21,859,370
- Meredith A Tennis$3,445,078
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungGeneticGene ExpressionLung DiseasesGenomicsResearch PersonnelTrainingAccountingPulmonary HypertensionGenesPathway InteractionsBioinformaticsDesignBasePathologyMemberResourcesComplexHuman DiseaseCellsPersonsTraining ProgramsSuccessMolecular
Grant awards (68)
Indiana Clinical and Translational Sciences Institute$5,264,717
UL1 · FY2019 · TR
IU training Program in Molecular Physiology and Clinical Mechanisms of Lung Disease$245,539
T32 · FY2019 · HL · contact PI
Indiana Clinical and Translational Sciences Institute$5,307,842
UL1 · FY2018 · TR
IU training Program in Molecular Physiology and Clinical Mechanisms of Lung Disease$272,580
T32 · FY2018 · HL · contact PI
IU training Program in Molecular Physiology and Clinical Mechanisms of Lung Disea$331,065
T32 · FY2017 · HL
IU training Program in Molecular Physiology and Clinical Mechanisms of Lung Disea$2,160
T32 · FY2017 · HL
Pulmonary Hypertension Breakthrough Initiative$2,518,872
R24 · FY2016 · HL · contact PI
IU training Program in Molecular Physiology and Clinical Mechanisms of Lung Disea$322,369
T32 · FY2016 · HL
GENE EXPRESSION CORE$131,860
P30 · FY2016 · CA · contact PI
Pulmonary Hypertension Breakthrough Initiative$1,969,871
R24 · FY2015 · HL · contact PI
Pulmonary Hypertension Breakthrough Initiative$564,952
R24 · FY2015 · HL · contact PI
IU training Program in Molecular Physiology and Clinical Mechanisms of Lung Disea$315,340
T32 · FY2015 · HL
GENE EXPRESSION CORE$132,313
P30 · FY2015 · CA · contact PI
Pulmonary Hypertension Breakthrough Initiative$2,557,971
R24 · FY2014 · HL · contact PI
Multidisciplinary Research Training in Respiratory Disease$500,863
T32 · FY2014 · HL · contact PI
GENE EXPRESSION CORE$127,977
P30 · FY2014 · CA · contact PI
Multidisciplinary Research Training in Respiratory Disease$846,271
T32 · FY2013 · HL · contact PI
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer$564,154
R01 · FY2013 · CA · contact PI
Mechanisms of Prostacyclin signaling in Pulmonary Arterial Hypertension$300,464
P01 · FY2013 · HL · contact PI
GENE EXPRESSION CORE$129,189
P30 · FY2013 · CA · contact PI
GENE EXPRESSION CORE$961
P30 · FY2013 · CA · contact PI
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer$601,421
R01 · FY2012 · CA · contact PI
Colorado Career Development Program in the Genetics and Genomics of Lung Diseases$399,600
K12 · FY2012 · HL · contact PI
Mechanisms of Prostacyclin signaling in Pulmonary Arterial Hypertension$346,802
P01 · FY2012 · HL · contact PI
GENE EXPRESSION CORE$132,147
P30 · FY2012 · CA · contact PI
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer$602,705
R01 · FY2011 · CA · contact PI
Mechanisms of Prostacyclin signaling in Pulmonary Arterial Hypertension$314,170
P01 · FY2011 · HL · contact PI
Prostacyclin Synthase and Receptors in Pulmonary Arterial Hypertension$114,750
R01 · FY2011 · HL · contact PI
Lung Genomics Research Consortium$3,759,656
RC2 · FY2010 · HL
Lung Genomics Research Consortium$1,654,805
RC2 · FY2010 · HL
Molecular Physiology Core Applied to Acute Lung Injury$514,028
P30 · FY2010 · HL · contact PI
Colorado Career Development Program in the Genetics and Genomics of Lung Diseases$399,600
K12 · FY2010 · HL · contact PI
Mechanisms of Prostacyclin signaling in Pulmonary Arterial Hypertension$307,049
P01 · FY2010 · HL · contact PI
GENE EXPRESSION CORE$139,980
P30 · FY2010 · CA · contact PI
Prostacyclin Synthase and Receptors in Pulmonary Arterial Hypertension$114,750
R01 · FY2010 · HL · contact PI
53rd Annual Thomas L Petty Aspen Lung Conference: Systems Biology of Lung Disease$15,000
R13 · FY2010 · HL · contact PI
Lung Genomics Research Consortium$5,987,215
RC2 · FY2009 · HL
Molecular Physiology Core Applied to Acute Lung Injury$527,802
P30 · FY2009 · HL · contact PI
Colorado Career Development Program in the Genetics and Genomics of Lung Diseases$399,600
K12 · FY2009 · HL · contact PI
Mechanisms of Prostacyclin signaling in Pulmonary Arterial Hypertension$225,652
P01 · FY2009 · HL · contact PI
GENE EXPRESSION CORE$148,080
P30 · FY2009 · CA · contact PI
Prostacyclin Synthase and Receptors in Pulmonary Arterial Hypertension$115,125
R01 · FY2009 · HL · contact PI
Prostacyclin Synthase and Receptors in Pulmonary Arterial Hypertension$18,090
R01 · FY2009 · HL · contact PI
Colorado Career Development Program in the Genetics and Genomics of Lung Diseases$399,600
K12 · FY2008 · HL · contact PI
Prostacyclin Synthase and Receptors in Pulmonary Arterial Hypertension$321,518
R01 · FY2008 · HL · contact PI
GENE EXPRESSION CORE$139,247
P30 · FY2008 · CA · contact PI
Colorado Career Development Program in the Genetics and Genomics of Lung Diseases$399,600
K12 · FY2007 · HL · contact PI
GENE EXPRESSION CORE$135,465
P30 · FY2007 · CA · contact PI
Molecular Biology Core$266,128
P01 · FY2006 · HL · contact PI
COLORADO CTSA PLANNING GRANT$231,000
P20 · FY2006 · RR · contact PI
Colorado CTSA Planning Grant$231,000
P20 · FY2006 · RR · contact PI
GENE EXPRESSION CORE$75,140
P30 · FY2006 · CA · contact PI
Expression Analysis to Study Disease Pathogenesis$767,020
R01 · FY2005 · HL
Molecular Biology Core$252,187
P01 · FY2005 · HL
Prostacyclin synthase and prostacyclin receptor in PH$232,637
P01 · FY2005 · HL
Expression Analysis to Study Disease Pathogenesis$766,064
R01 · FY2004 · HL
Affymetrix GeneChip Instrument System$254,945
S10 · FY2004 · RR
GENECHIP INSTRUMENT SYST: GENE EXPRESSION &VASCULAR BIOL, CVD$127,473
S10 · FY2004 · RR
GENECHIP INSTRUMENT SYST: GENE EXPRESSION &PULMONARY DIS$127,472
S10 · FY2004 · RR
Expression Analysis to Study Disease Pathogenesis$754,770
R01 · FY2003 · HL
Expression Analysis to Study Disease Pathogenesis$744,067
R01 · FY2002 · HL
CORE--GENE EXPRESSION$250,404
P30 · FY2002 · CA
CORE--GENE EXPRESSION$250,404
P30 · FY2002 · CA
Molecular Biology Core$237,381
P01 · FY2002 · HL
Prostacyclin synthase and prostacyclin receptor in PH$213,409
P01 · FY2002 · HL
CORE--GENE EXPRESSION$250,404
P30 · FY2001 · CA
Prostacyclin synthase and prostacyclin receptor in PH$0
P01 · FY2001 · HL
CORE--GENE EXPRESSION$0
P30 · FY2001 · CA